April 19, 2012

NEW IDEA ON HUMAN GENOME SCIENCES INC. (HGSI)

This post was published earlier on ZYX Buy Change Alert

Last year  Human Genome Sciences Inc. (HGSI) successfully introduced the first new treatment for Lupus in a very long time.  GlaxoSmithKline (GSK), the big drug giant, is Human Genome’s partner.

Human Genome has disclosed that it received an unsolicited $13.00 per share cash offer from GlaxoSmithKline.

It is likely that the deal will ultimately get done at a premium to the present bid of $13.00 per share.

Buy zone is $12.50 to $13.56.  To control risk consider not exceeding 20% of full core position size.  Stop zone is$11.48 to  $11.75.  Target zone is $16 to $18.… Please click here or the title below to read more.

Read More

9 Winners. 9 Losers. Gold, Silver & AI Trade Zones.

9 Winners. 9 Losers.
Gold, Silver & AI Trade Zones.

A new market cycle is forming.

AI, Metals &
Memory Playbook

See where sophisticated investors are positioning across software, precious metals, and AI memory.

AI is power hungry. Investors will make a fortune from nuclear power for AI.
Get the list of 12 nuclear power stocks to grab your share of the profits.

Skip to content